Biography
Professional Summary
Education & Certifications
- Medical Education: Stanford University School of Medicine (1998) CA
- Residency: Stanford University Dermatology Residency (2002) CA
- Internship: University of Colorado Internal Medicine Residency (1999) CO
- Board Certification: American Board of Dermatology, Dermatology (2002)
- Ph.D., Stanford University, Cancer Biology (1998)
- M.D., Stanford University (1998)
- B.S., Stanford University, Biological Sciences (1988)
Honors & Awards
- Clinical Immunology Faculty Scholarship Award, Center for Clinical Immunology at Stanford (2003-2006)
- Medical Dermatology Development Award, Dermatology Foundation (2004-2007)
Administrative Appointments
- Associate Director, Residency Program (2013 - Present)
- Founding member, North American Rheumatologic Dermatology Society (NARDS) (2006 - Present)
Publications
-
Cutaneous vasculitis
Fiorentino, D. F. (2003). Cutaneous vasculitis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 48(3), 311–40. -
Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions
Fiorentino, D. F., Nguyen, J. C., Egbert, B. M., & Swetter, S. M. (2004). Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 50(3), 476–78. -
RAPAMYCIN SELECTIVELY INHIBITS INTERLEUKIN-2 ACTIVATION OF P70 S6 KINASE
Kuo, C. J., Chung, J. K., Fiorentino, D. F., Flanagan, W. M., Blenis, J., & Crabtree, G. R. (1992). RAPAMYCIN SELECTIVELY INHIBITS INTERLEUKIN-2 ACTIVATION OF P70 S6 KINASE. NATURE, 358(6381), 70–73. -
Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil
Hantash, B., & Fiorentino, D. (2006). Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil. ARCHIVES OF DERMATOLOGY, 142(1), 109–110. -
Digital ulcers in patients with systemic sclerosis
Chung, L., & Fiorentino, D. (2006). Digital ulcers in patients with systemic sclerosis. AUTOIMMUNITY REVIEWS, 5(2), 125–28. -
A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis
Chung, L., & Fiorentino, D. (2006). A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 54(5), 880–82. -
PRODUCTION OF IL-10 BY CD4+ LYMPHOCYTES-T CORRELATES WITH DOWN-REGULATION OF TH1 CYTOKINE SYNTHESIS IN HELMINTH INFECTION
Sher, A., Fiorentino, D., Caspar, P., Pearce, E., & Mosmann, T. (1991). PRODUCTION OF IL-10 BY CD4+ LYMPHOCYTES-T CORRELATES WITH DOWN-REGULATION OF TH1 CYTOKINE SYNTHESIS IN HELMINTH INFECTION. JOURNAL OF IMMUNOLOGY, 147(8), 2713–2716. -
DIVERSITY OF CYTOKINE SYNTHESIS AND FUNCTION OF MOUSE CD4+ T-CELLS
Mosmann, T. R., SCHUMACHER, J. H., STREET, N. F., Budd, R., OGARRA, A., Fong, T. A. T., … Fiorentino, D. F. (1991). DIVERSITY OF CYTOKINE SYNTHESIS AND FUNCTION OF MOUSE CD4+ T-CELLS. IMMUNOLOGICAL REVIEWS, 123, 209–229. -
Epidemiology of FASD in a province in Italy: Prevalence and characteristics of children in a random sample of schools
May, P. A., Fiorentino, D., Gossage, J. P., Kalberg, W. O., Hoyme, H. E., Robinson, L. K., … Ceccanti, M. (2006). Epidemiology of FASD in a province in Italy: Prevalence and characteristics of children in a random sample of schools. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 30(9), 1562–1575. -
Systemic and locatized scleroderma
Chung, L., Lin, J., Furst, D. E., & Fiorentino, D. (2006). Systemic and locatized scleroderma. CLINICS IN DERMATOLOGY, 24(5), 374–92. -
Successful use of rituximab for cutaneous vasculitis
Chung, L., Funke, A. A., Chakravarty, E. F., Callen, J. P., & Fiorentino, D. F. (2006). Successful use of rituximab for cutaneous vasculitis. ARCHIVES OF DERMATOLOGY, 142(11), 1407–10. -
Update on cutaneous vasculitis
Grzeszkiewicz, T. M., & Fiorentino, D. F. (2006). Update on cutaneous vasculitis. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 25(4), 221–25. -
A pilot trial of rituximab in the treatment of patients with dermatomyositis
Chung, L., Genovese, M. C., & Fiorentino, D. F. (2007). A pilot trial of rituximab in the treatment of patients with dermatomyositis. ARCHIVES OF DERMATOLOGY, 143(6), 763–67. -
Nephrogenic systemic fibrosis - Relationship to gadolinium and response to photopheresis
Richmond, H., Zwerner, J., Kim, Y., & Fiorentino, D. (2007). Nephrogenic systemic fibrosis - Relationship to gadolinium and response to photopheresis. ARCHIVES OF DERMATOLOGY, 143(8), 1025–30. -
Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis
Hantash, B. M., Chiang, D., Kohler, S., & Fiorentino, D. (2008). Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 58(4), 661–64. -
Mycophenolate mofetil
Zwerner, J., & Fiorentino, D. (2007). Mycophenolate mofetil. DERMATOLOGIC THERAPY, 20(4), 229–38. -
Localized scleroderma and systemic sclerosis: Is there a connection?
Gupta, R. A., & Fiorentino, D. (2007). Localized scleroderma and systemic sclerosis: Is there a connection? BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 21(6), 1025–36. -
IL-10 ACTS ON THE ANTIGEN-PRESENTING CELL TO INHIBIT CYTOKINE PRODUCTION BY TH1 CELLS
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & OGARRA, A. (1991). IL-10 ACTS ON THE ANTIGEN-PRESENTING CELL TO INHIBIT CYTOKINE PRODUCTION BY TH1 CELLS. JOURNAL OF IMMUNOLOGY, 146(10), 3444–3451. -
Dermatomyositis.
Krathen, M. S., Fiorentino, D., & Werth, V. P. (2008). Dermatomyositis. Current Directions in Autoimmunity, 10, 313–332. -
ISOLATION AND EXPRESSION OF HUMAN CYTOKINE SYNTHESIS INHIBITORY FACTOR CDNA CLONES - HOMOLOGY TO EPSTEIN-BARR-VIRUS OPEN READING FRAME BCRFI
Vieira, P., DEWAALMALEFYT, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., … Moore, K. W. (1991). ISOLATION AND EXPRESSION OF HUMAN CYTOKINE SYNTHESIS INHIBITORY FACTOR CDNA CLONES - HOMOLOGY TO EPSTEIN-BARR-VIRUS OPEN READING FRAME BCRFI. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 88(4), 1172–1176. -
Type I Interferon in the Induction or Exacerbation of Dermatomyositis What This Observation Tells Us About the Naturally Occurring Disease
Fiorentino, D. F. (2008). Type I Interferon in the Induction or Exacerbation of Dermatomyositis What This Observation Tells Us About the Naturally Occurring Disease. ARCHIVES OF DERMATOLOGY, 144(10), 1379–1382. -
Imatinib in the Treatment of Nephrogenic Systemic Fibrosis
Chandran, S., Petersen, J., Jacobs, C., Forentino, D., Doeden, K., & Lafayette, R. A. (2009). Imatinib in the Treatment of Nephrogenic Systemic Fibrosis. AMERICAN JOURNAL OF KIDNEY DISEASES, 53(1), 129–32. -
Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis
Chung, L., Fiorentino, D. F., Benbarak, M. J., Adler, A. S., Mariano, M. M., Paniagua, R. T., … Robinson, W. H. (2009). Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis. ARTHRITIS AND RHEUMATISM, 60(2), 584–91. -
MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon A Randomized, Controlled Trial
Chung, L., Shapiro, L., Fiorentino, D., Baron, M., Shanahan, J., Sule, S., … Wigley, F. M. (2009). MQX-503, a Novel Formulation of Nitroglycerin, Improves the Severity of Raynaud's Phenomenon A Randomized, Controlled Trial. ARTHRITIS AND RHEUMATISM, 60(3), 870–77. -
IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & OGARRA, A. (1991). IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES. JOURNAL OF IMMUNOLOGY, 147(11), 3815–3822. -
HETEROGENEITY OF MOUSE HELPER T-CELLS - EVIDENCE FROM BULK CULTURES AND LIMITING DILUTION CLONING FOR PRECURSORS OF TH1 AND TH2 CELLS
Street, N. E., SCHUMACHER, J. H., Fong, T. A. T., Bass, H., Fiorentino, D. F., LEVERAH, J. A., & Mosmann, T. R. (1990). HETEROGENEITY OF MOUSE HELPER T-CELLS - EVIDENCE FROM BULK CULTURES AND LIMITING DILUTION CLONING FOR PRECURSORS OF TH1 AND TH2 CELLS. JOURNAL OF IMMUNOLOGY, 144(5), 1629–1639. -
Conditioned Pharmacotherapeutic Effects: A Preliminary Study
Ader, R., Mercurio, M. G., Walton, J., James, D., Davis, M., Ojha, V., … Fiorentino, D. (2010). Conditioned Pharmacotherapeutic Effects: A Preliminary Study. PSYCHOSOMATIC MEDICINE, 72(2), 192–97. -
Tyrosine kinases in inflammatory dermatologic disease
Paniagua, R. T., Fiorentino, D. F., Chung, L., & Robinson, W. H. (2011). Tyrosine kinases in inflammatory dermatologic disease. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(2), 389–403. -
The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytes
Fiorentino, D. F., Chen, R. O., STEWART, D. B., Brown, K. K., & Sundram, U. N. (2011). The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytes. BRITISH JOURNAL OF DERMATOLOGY, 164(5), 996–1003. -
A Pilot Study of Etanercept Treatment for Pemphigus Vulgaris
Fiorentino, D. F., Garcia, M. S., Rehmus, W., & Kimball, A. B. (2011). A Pilot Study of Etanercept Treatment for Pemphigus Vulgaris. ARCHIVES OF DERMATOLOGY, 147(1), 117–18. -
Pathogenesis of dermatomyositis: role of cytokines and interferon.
Kao, L., Chung, L., & Fiorentino, D. F. (2011). Pathogenesis of dermatomyositis: role of cytokines and interferon. Current Rheumatology Reports, 13(3), 225–32. -
ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR IL-4, IL-5, IL-6, AND A NEW TH2-SPECIFIC CYTOKINE (IL-10), CYTOKINE SYNTHESIS INHIBITORY FACTOR, BY USING A SOLID-PHASE RADIOIMMUNOADSORBENT ASSAY
Mosmann, T. R., SCHUMACHER, J. H., Fiorentino, D. F., LEVERAH, J., Moore, K. W., & Bond, M. W. (1990). ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR IL-4, IL-5, IL-6, AND A NEW TH2-SPECIFIC CYTOKINE (IL-10), CYTOKINE SYNTHESIS INHIBITORY FACTOR, BY USING A SOLID-PHASE RADIOIMMUNOADSORBENT ASSAY. JOURNAL OF IMMUNOLOGY, 145(9), 2938–2945. -
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
Fiorentino, D., Chung, L., Zwerner, J., Rosen, A., & Casciola-Rosen, L. (2011). The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(1), 25–34. -
HOMOLOGY OF CYTOKINE SYNTHESIS INHIBITORY FACTOR (IL-10) TO THE EPSTEIN-BARR-VIRUS GENE BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., TROUNSTINE, M. L., Khan, T. A., & Mosmann, T. R. (1990). HOMOLOGY OF CYTOKINE SYNTHESIS INHIBITORY FACTOR (IL-10) TO THE EPSTEIN-BARR-VIRUS GENE BCRFI. SCIENCE, 248(4960), 1230–1234. -
EXPRESSION OF INTERLEUKIN-10 ACTIVITY BY EPSTEIN-BARR-VIRUS PROTEIN BCRF1
Hsu, D. H., Malefyt, R. D., Fiorentino, D. F., Dang, M. N., Vieira, P., Devries, J., … Moore, K. W. (1990). EXPRESSION OF INTERLEUKIN-10 ACTIVITY BY EPSTEIN-BARR-VIRUS PROTEIN BCRF1. SCIENCE, 250(4982), 830–832. -
Prevalence of Children with Severe Fetal Alcohol Spectrum Disorders in Communities Near Rome, Italy: New Estimated Rates Are Higher than Previous Estimates
May, P. A., Fiorentino, D., Coriale, G., Kalberg, W. O., Hoyme, H. E., Aragon, A. S., … Ceccanti, M. (2011). Prevalence of Children with Severe Fetal Alcohol Spectrum Disorders in Communities Near Rome, Italy: New Estimated Rates Are Higher than Previous Estimates. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 8(6), 2331–2351. -
Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection
Fiorentino, D., & Casciola-Rosen, L. (2012). Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection. ARTHRITIS AND RHEUMATISM, 64(2), 346–349. -
Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis.
Arefiev, K., Fiorentino, D. F., & Chung, L. (2011). Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis. International Journal of Rheumatology, 2011, 201787-? -
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
Wong, D., Kea, B., Pesich, R., Higgs, B. W., Zhu, W., Brown, P., … Fiorentino, D. (2012). Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases. PLOS ONE, 7(1). -
Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment
Strand, V., Sharp, V., Koenig, A. S., Park, G., Shi, Y., Wang, B., … Fiorentino, D. (2012). Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. ANNALS OF THE RHEUMATIC DISEASES, 71(7), 1143–50. -
Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients
Higgs, B. W., Zhu, W., Richman, L., Fiorentino, D. F., Greenberg, S. A., Jallal, B., & Yao, Y. (2012). Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 15(1), 25–35. -
A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies Report of 2 Cases and Review of the Literature
Chaisson, N. F., Paik, J., Orbai, A.-M., Casciola-Rosen, L., Fiorentino, D., Danoff, S., & Rosen, A. (2012). A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies Report of 2 Cases and Review of the Literature. MEDICINE, 91(4), 220–228. -
Skin disease in dermatomyositis
Zaba, L. C., & Fiorentino, D. F. (2012). Skin disease in dermatomyositis. CURRENT OPINION IN RHEUMATOLOGY, 24(6), 597–601. -
Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab
Sarin, K. Y., & Fiorentino, D. (2012). Treatment of Recalcitrant Eosinophilic Cellulitis With Adalimumab. ARCHIVES OF DERMATOLOGY, 148(9), 990–92. -
Clinical presentation and evaluation of dermatomyositis.
Marvi, U., Chung, L., & Fiorentino, D. F. (2012). Clinical presentation and evaluation of dermatomyositis. Indian Journal of Dermatology, 57(5), 375–81. -
Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases
de Souza, A., Ali-Shaw, T., Reddy, S. M., Fiorentino, D., & Strober, B. E. (2013). Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases. BRITISH JOURNAL OF DERMATOLOGY, 168(1), 210–12. -
Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey.
Linos, E., Fiorentino, D., Lingala, B., Krishnan, E., & Chung, L. (2013). Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey. Arthritis Research & Therapy, 15(1), R7-? -
Localized cutaneous fibrosing disorders.
Yaqub, A., Chung, L., Rieger, K. E., & Fiorentino, D. F. (2013). Localized cutaneous fibrosing disorders. Rheumatic Diseases Clinics of North America, 39(2), 347–64. -
2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989). 2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES. JOURNAL OF EXPERIMENTAL MEDICINE, 170(6), 2081–2095. -
MOLECULAR ANALYSIS OF THE INTERACTION OF CALCINEURIN WITH DRUG-IMMUNOPHILIN COMPLEXES
Clipstone, N. A., Fiorentino, D. F., & Crabtree, G. R. (1994). MOLECULAR ANALYSIS OF THE INTERACTION OF CALCINEURIN WITH DRUG-IMMUNOPHILIN COMPLEXES. JOURNAL OF BIOLOGICAL CHEMISTRY, 269(42), 26431–26437. -
IMMUNOPHILINS INTERACT WITH CALCINEURIN IN THE ABSENCE OF EXOGENOUS IMMUNOSUPPRESSIVE LIGANDS
Cardenas, M. E., Hemenway, C., Muir, R. S., Ye, R., Fiorentino, D., & Heitman, J. (1994). IMMUNOPHILINS INTERACT WITH CALCINEURIN IN THE ABSENCE OF EXOGENOUS IMMUNOSUPPRESSIVE LIGANDS. EMBO JOURNAL, 13(24), 5944–5957. -
TOR KINASE DOMAINS ARE REQUIRED FOR 2 DISTINCT FUNCTIONS, ONLY ONE OF WHICH IS INHIBITED BY RAPAMYCIN
Zheng, X. F., Fiorentino, D., Chen, J., Crabtree, G. R., & Schreiber, S. L. (1995). TOR KINASE DOMAINS ARE REQUIRED FOR 2 DISTINCT FUNCTIONS, ONLY ONE OF WHICH IS INHIBITED BY RAPAMYCIN. CELL, 82(1), 121–130. -
The mechanism of action of cyclosporin A and FK506
Ho, S., Clipstone, N., Timmermann, L., Northrop, J., Graef, I., Fiorentino, D., … Crabtree, G. R. (1996). The mechanism of action of cyclosporin A and FK506. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 80(3), S40–S45. -
Characterization of Saccharomyces cerevisiae dna2 mutants suggests a role for the helicase late in S phase
Fiorentino, D. F., & Crabtree, G. R. (1997). Characterization of Saccharomyces cerevisiae dna2 mutants suggests a role for the helicase late in S phase. MOLECULAR BIOLOGY OF THE CELL, 8(12), 2519–2537. -
Consensus Guidelines for the Management of Plaque Psoriasis
Hsu, S., Papp, K. A., Lebwohl, M. G., Bagel, J., Blauvelt, A., Duffin, K. C., … Bebo, B. F. (2012). Consensus Guidelines for the Management of Plaque Psoriasis. ARCHIVES OF DERMATOLOGY, 148(1), 95–102. -
International consensus for a definition of disease flare in lupus
Ruperto, N., HANRAHAN, L. M., Alarcon, G. S., Belmont, H. M., Brey, R. L., Brunetta, P., … Merrill, J. T. (2011). International consensus for a definition of disease flare in lupus. LUPUS, 20(5), 453–62. -
Comparison of the reliability & validity of outcome instruments for cutaneous dermatomyositis
Quain, R. D., Bangert, C. C., Costner, M., Connolly, M. K., Dugan, E., Tanikawa, A., … Werth, V. P. (2007). Comparison of the reliability & validity of outcome instruments for cutaneous dermatomyositis. Presented at the 68th Annual Meeting of the Society-for-Investigative-Dermatology, LOS ANGELES,CA: NATURE PUBLISHING GROUP. -
Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis
Klein, R. Q., Bangert, C. A., Costner, M., Connolly, M. K., Tanikawa, A., Okawa, J., … Werth, V. P. (2008). Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. BRITISH JOURNAL OF DERMATOLOGY, 159(4), 887–94. -
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (2012). Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI. JOURNAL OF IMMUNOLOGY, 189(5), 1230–1234. -
A Pilot Study of Abatacept for the Treatment of Patients with Diffuse Cutaneous Systemic Sclerosis.
Chakravarty, E. F., Fiorentino, D., Bennett, M., & Chung, L. (2011). A Pilot Study of Abatacept for the Treatment of Patients with Diffuse Cutaneous Systemic Sclerosis. ARTHRITIS AND RHEUMATISM, 63(10), S274–S275. -
Molecular framework for response to imatinib mesylate in systemic sclerosis
Chung, L., Fiorentino, D. F., Benbarak, M. J., Adler, A. S., Mariano, M. M., Paniagua, R. T., … Robinson, W. H. (2008). Molecular framework for response to imatinib mesylate in systemic sclerosis. ARTHRITIS AND RHEUMATISM. SAN FRANCISCO,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: WILEY-BLACKWELL. -
Evaluation of an imatinib response gene signature in patients with systemic sclerosis
Chung, L., Ruiz, P., Wood, T., Shoor, S., Robinson, W., Whitfield, M., … Fiorentino, D. (2010). Evaluation of an imatinib response gene signature in patients with systemic sclerosis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. CLINICAL & EXPER RHEUMATOLOGY. -
Immune Responses to NXP-2 and TIF-g Are Associated with Distinct Clinical Phenotypes and Prognosis for Skin Disease in Dermatomyositis Patients.
Fiorentino, D., Chung, L., Zaba, L., Lingala, B., Rosen, A., & Casciola-Rosen, L. (2012). Immune Responses to NXP-2 and TIF-g Are Associated with Distinct Clinical Phenotypes and Prognosis for Skin Disease in Dermatomyositis Patients. ARTHRITIS AND RHEUMATISM, 64(10), S828–S828. -
Treatment recommendations for psoriatic arthritis
Ritchlin, C. T., Kavanaugh, A., Gladman, D. D., Mease, P. J., Helliwell, P., Boehncke, W.-H., … Taylor, W. J. (2009). Treatment recommendations for psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES, 68(9), 1387–1394. -
Molecular Profiling to Diagnose a Case of Atypical Dermatomyositis.
Molecular Profiling to Diagnose a Case of Atypical Dermatomyositis. (2013). The Journal of Investigative Dermatology. -
Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?
Fleming, J. N., Nash, R. A., McLeod, D. O., Fiorentino, D. F., Shulman, H. M., Connolly, M. K., … Schwartz, S. M. (2008). Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype? PLOS ONE, 3(1). -
HETEROGENEITY OF MOUSE HELPER T-CELLS AND CROSS-REGULATION OF TH1 AND TH2 CLONES
Mosmann, T. R., Street, N. E., Fiorentino, D. F., Bond, M. W., Fong, T. A. T., Schumacher, J., … Moore, K. W. (1989). HETEROGENEITY OF MOUSE HELPER T-CELLS AND CROSS-REGULATION OF TH1 AND TH2 CLONES. Presented at the 7TH INTERNATIONAL CONGRESS OF IMMUNOLOGY, BERLIN,FED REP GER: SPRINGER-VERLAG BERLIN. -
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
Strand, V., Fiorentino, D., Hu, C. C., Day, R. M., Stevens, R. M., & Papp, K. A. (2013). Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study. HEALTH AND QUALITY OF LIFE OUTCOMES, 11. -
Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey
Linos, E., Fiorentino, D., Lingala, B., Krishnan, E., & Chung, L. (2013). Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey. ARTHRITIS RESEARCH & THERAPY, 15(1). -
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Higgs, B. W., Liu, Z., White, B., Zhu, W., White, W. I., Morehouse, C., … Yao, Y. (2011). Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. ANNALS OF THE RHEUMATIC DISEASES, 70(11), 2029–2036. -
Quality of life in dermatomyositis
Goreshi, R., Chock, M., Foering, K., Feng, R., Okawa, J., Rose, M., … Werth, V. (2011). Quality of life in dermatomyositis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(6), 1107–1116. -
Genomic signatures characterize leukocyte infiltration in myositis muscles
Zhu, W., Streicher, K., Shen, N., Higgs, B. W., Morehouse, C., Greenlees, L., … Yao, Y. (2012). Genomic signatures characterize leukocyte infiltration in myositis muscles. BMC MEDICAL GENOMICS, 5. -
Modification of the Cutaneous Dermatomyositis Disease Area and Severity Index, an outcome instrument
Yassaee, M., Fiorentino, D., Okawa, J., Taylor, L., Coley, C., Troxel, A. B., & Werth, V. P. (2010). Modification of the Cutaneous Dermatomyositis Disease Area and Severity Index, an outcome instrument. BRITISH JOURNAL OF DERMATOLOGY, 162(3), 669–673. -
Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1?.
Fiorentino, D. F., Chung, L. S., Christopher-Stine, L., Zaba, L., Li, S., Mammen, A. L., … Casciola-Rosen, L. (2013). Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1?. Arthritis and Rheumatism, 65(11), 2954–62. -
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?.
Fiorentino, D. F., Chung, L. S., Christopher-Stine, L., Zaba, L., Li, S., Mammen, A. L., … Casciola-Rosen, L. (2013). Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?. Arthritis and Rheumatism, 65(11), 2954–62. -
Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis: Higher Mortality Than Patients With Lupus and Rheumatoid Arthritis
Dave, A. J., Fiorentino, D., Lingala, B., Krishnan, E., & Chung, L. (2014). Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis: Higher Mortality Than Patients With Lupus and Rheumatoid Arthritis. ARTHRITIS CARE & RESEARCH, 66(2), 323–27. -
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
Higgs, B. W., Zhu, W., Morehouse, C., White, W. I., Brohawn, P., Guo, X., … Yao, Y. (2014). A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients. ANNALS OF THE RHEUMATIC DISEASES, 73(1), 256–262. -
The plasma cell signature in autoimmune disease.
Streicher, K., Morehouse, C. A., Groves, C. J., Rajan, B., Pilataxi, F., Lehmann, K. P., … Ranade, K. (2014). The plasma cell signature in autoimmune disease. Arthritis & Rheumatology (Hoboken, N.J.), 66(1), 173–184. -
Localized cutaneous fibrosing disorders.
Yaqub, A., Chung, L., Rieger, K. E., & Fiorentino, D. F. (2013). Localized cutaneous fibrosing disorders. Rheumatic Diseases Clinics of North America, 39(2), 347–364. -
Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.
Valenzuela, A., Chung, L., Casciola-Rosen, L., & Fiorentino, D. (2014). Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatology, 150(7), 724–29. -
Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study.
Chung, L., Ball, K., Yaqub, A., Lingala, B., & Fiorentino, D. (2014). Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study. Journal of the American Academy of Dermatology, 71(2), 400–401. -
Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease.
Narang, N. S., Casciola-Rosen, L., Li, S., Chung, L., & Fiorentino, D. F. (2015). Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care & Research, 67(5), 667–72. -
Surgical treatment of systemic sclerosis-is it justified to offer peripheral sympathectomy earlier in the disease process?
Momeni, A., Sorice, S. C., Valenzuela, A., Fiorentino, D. F., Chung, L., & Chang, J. (2015). Surgical treatment of systemic sclerosis-is it justified to offer peripheral sympathectomy earlier in the disease process? Microsurgery, 35(6), 441–46. -
Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria
VALENZUELA, A., Yaqub, A., Fiorentino, D., Krishnan, E., & Chung, L. (2015). Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 44(3), 253–255. -
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis.
Chakravarty, E. F., Martyanov, V., Fiorentino, D., Wood, T. A., Haddon, D. J., Jarrell, J. A., … Chung, L. (2015). Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis. Arthritis Research & Therapy, 17, 159-? -
Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.
Valenzuela, A., Chung, L., Casciola-Rosen, L., & Fiorentino, D. (2014). Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatology, 150(7), 724–29. -
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
Chakravarty, E. F., Martyanov, V., Fiorentino, D., Wood, T. A., Haddon, D. J., Jarrell, J. A., … Chung, L. (2015). Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis. ARTHRITIS RESEARCH & THERAPY, 17. -
PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjogren's syndrome
Fiorentino, D. F., Presby, M., Baer, A. N., Petri, M., Rieger, K. E., Soloski, M., … Casciola-Rosen, L. (2016). PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjogren's syndrome. ANNALS OF THE RHEUMATIC DISEASES, 75(6), 1145–51. -
Leukotriene B-4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension
Qian, J., Tian, W., Jiang, X., Tamosiuniene, R., Sung, Y. K., Shuffle, E. M., … Nicolls, M. R. (2015). Leukotriene B-4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension. HYPERTENSION, 66(6), 1227–39. -
Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change
Anyanwu, C. O., Fiorentino, D. F., Chung, L., Dzuong, C., Wang, Y., Okawa, J., … Werth, V. P. (2015). Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change. BRITISH JOURNAL OF DERMATOLOGY, 173(4), 969–74. -
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Kalb, R. E., Fiorentino, D. F., Lebwohl, M. G., Toole, J., Poulin, Y., Cohen, A. D., … Leonardi, C. L. (2015). Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA DERMATOLOGY, 151(9), 961–69. -
Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study
Valenzuela, A., Baron, M., Herrick, A. L., Proudman, S., Stevens, W., Rodriguez-Reyna, T. S., … Chung, L. (2016). Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. SEMINARS IN ARTHRITIS AND RHEUMATISM, 46(3), 344–49. -
Abstract 46: surgical treatment of systemic sclerosis: re-thinking the role and timing of peripheral sympathectomy.
Momeni, A., Sorice, S. C., Valenzuela, A., Fiorentino, D. F., Chung, L., & Chang, J. (2014). Abstract 46: surgical treatment of systemic sclerosis: re-thinking the role and timing of peripheral sympathectomy. Plastic and Reconstructive Surgery, 133(4), 1010-? -
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])
Strober, B. E., Bissonnette, R., Fiorentino, D., Kimball, A. B., Naldi, L., Shear, N. H., … Lebwohl, M. G. (2016). Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]). JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(5), 851-? -
Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets.
Cho, H. G., Fiorentino, D., Lewis, M., Sirota, M., & Sarin, K. Y. (2016). Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets. Journal of Investigative Dermatology, 136(7), 1517–20. -
Ovoid Palatal Patch in Dermatomyositis: A Novel Finding Associated With Anti-TIF1? (p155) Antibodies.
Bernet, L. L., Lewis, M. A., Rieger, K. E., Casciola-Rosen, L., & Fiorentino, D. F. (2016). Ovoid Palatal Patch in Dermatomyositis: A Novel Finding Associated With Anti-TIF1? (p155) Antibodies. JAMA Dermatology, 152(9), 1049–51. -
Pillars Article: IL-10 Inhibits Cytokine Production by Activated Macrophages. J. Immunol. 1991. 147: 3815-3822.
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O'Garra, A. (2016). Pillars Article: IL-10 Inhibits Cytokine Production by Activated Macrophages. J. Immunol. 1991. 147: 3815-3822. Journal of Immunology , 197(5), 1539–1546. -
Pathogenesis of Dermatomyositis: Role of Cytokines and Interferon
Kao, L., Chung, L., & Fiorentino, D. F. (2011). Pathogenesis of Dermatomyositis: Role of Cytokines and Interferon. CURRENT RHEUMATOLOGY REPORTS, 13(3), 225–32. -
IL-10 ACTS ON THE ANTIGEN-PRESENTING CELL TO INHIBIT CYTOKINE PRODUCTION BY Th1 CELLS
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O'Garra, A. (2016). IL-10 ACTS ON THE ANTIGEN-PRESENTING CELL TO INHIBIT CYTOKINE PRODUCTION BY Th1 CELLS. JOURNAL OF IMMUNOLOGY, 197(5), 1531–1538. -
Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea
Fett, N. M., Fiorentino, D., & Werth, V. P. (2016). Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea. DERMATOLOGIC CLINICS, 34(3), 243-? -
The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients.
Rogers, A., Chung, L., Li, S., Casciola-Rosen, L., & Fiorentino, D. F. (2017). The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients. Arthritis Care & Research. -
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity.
Lofgren, S., Hinchcliff, M., Carns, M., Wood, T., Aren, K., Arroyo, E., … Khatri, P. (2016). Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. JCI Insight, 1(21). -
Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-? Antibody, in Subjects with Discoid Lupus Erythematosus.
Werth, V. P., Fiorentino, D., Sullivan, B. A., Boedigheimer, M. J., Chiu, K., Wang, C., … Chung, J. B. (2017). Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-? Antibody, in Subjects with Discoid Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). -
IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O'Garra, A. (2016). IL-10 INHIBITS CYTOKINE PRODUCTION BY ACTIVATED MACROPHAGES. JOURNAL OF IMMUNOLOGY, 197(5), 1539–46. -
Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-gamma Antibody, in Patients With Discoid Lupus Erythematosus
Werth, V. P., Fiorentino, D., Sullivan, B. A., Boedigheimer, M. J., Chiu, K., Wang, C., … Chung, J. B. (2017). Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-gamma Antibody, in Patients With Discoid Lupus Erythematosus. ARTHRITIS & RHEUMATOLOGY, 69(5), 1028–34. -
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., … Vencovsky, J. (2017). 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. ARTHRITIS & RHEUMATOLOGY, 69(5), 898–910. -
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., … Vencovsky, J. (2017). 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. ANNALS OF THE RHEUMATIC DISEASES, 76(5). -
Cellular automata model of phase transition in binary mixtures
Vannozzi, C., Fiorentino, D., D'Amore, M., Rumshitzki, D. S., Dress, A., & Mauri, R. (2006). Cellular automata model of phase transition in binary mixtures. INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 45(8), 2892–96. -
Pregnancy outcomes in adult patients with dermatomyositis and polymyositis.
Kolstad, K. D., Fiorentino, D., Li, S., Chakravarty, E. F., & Chung, L. (2017). Pregnancy outcomes in adult patients with dermatomyositis and polymyositis. Seminars in Arthritis and Rheumatism. -
Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.
Wolstencroft, P. W., & Fiorentino, D. F. (2018). Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies. Current Rheumatology Reports, 20(5), 28. -
A multi-center crossover study of MQX-503, a topical formulation of nitroglycerin, in patients with Raynaud's phenomenon
Denton, C. P., Fiorentino, D., Herrick, A., Sule, S., Rothfield, N., Belch, J., … Wigley, F. M. (2007). A multi-center crossover study of MQX-503, a topical formulation of nitroglycerin, in patients with Raynaud's phenomenon. ARTHRITIS AND RHEUMATISM, 56(12), 4238. -
Dermatomyositis
Vleugels, R. A., Fiorentino, D. F., & Callen, J. P. (2014). Dermatomyositis. EVIDENCE-BASED DERMATOLOGY, 3RD EDITION, 531–44. -
IDENTIFICATION OF ICD-9 CODES ASSOCIATED WITH SCLERODERMA RENAL CRISIS
Vergara, A. V., Yaqub, A., Fiorentino, D., Krishnan, E., & Chung, L. (2014). IDENTIFICATION OF ICD-9 CODES ASSOCIATED WITH SCLERODERMA RENAL CRISIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 32(2), S115. -
Validation Of The ICD-CM-9 Code For Systemic Sclerosis Using Updated ACR/EULAR Classification Criteria
Yaqub, A., Chung, L., Fiorentino, D., & Krishnan, E. (2013). Validation Of The ICD-CM-9 Code For Systemic Sclerosis Using Updated ACR/EULAR Classification Criteria. ARTHRITIS AND RHEUMATISM, 65, S772–S773. -
Risk of malignancy associated with biologic therapy and methotrexate (MTX) in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Fiorentino, D., Ho, V., Lebwohl, M., Leite, L., Hopkins, L., Galindo, C., … Langley, R. (2017). Risk of malignancy associated with biologic therapy and methotrexate (MTX) in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 76(6), AB221. -
Identification of alpha-adrenergic agonists as potential therapeutic agents for dermatomyositis through drug-repurposing using public expression datasets
Cho, H. G., Fiorentino, D., Lewis, M., Sirota, M., & Sarin, K. (2016). Identification of alpha-adrenergic agonists as potential therapeutic agents for dermatomyositis through drug-repurposing using public expression datasets. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 136(5), S44. -
Current status of observations of malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) study
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Langholff, W. (2016). Current status of observations of malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) study. BRITISH JOURNAL OF DERMATOLOGY, 175, 59. -
Dermatomyositis Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: A Longitudinal Analysis
Lewis, M., Li, S., Chung, L., & Fiorentino, D. (2015). Dermatomyositis Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: A Longitudinal Analysis. ARTHRITIS & RHEUMATOLOGY, 67. -
Modelled analysis of serious infection risk in the treatment of psoriasis with biologics and systemic treatments in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Kalb, R., Fiorentino, D., Lebwohl, M., Leonardi, C., Toole, J., Poulin, Y., … Fakharzadeh, S. (2015). Modelled analysis of serious infection risk in the treatment of psoriasis with biologics and systemic treatments in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). BRITISH JOURNAL OF DERMATOLOGY, 173, 63–64. -
Muscle Disease in Systemic Sclerosis Is Associated with an Increased Risk for Cardiac Involvement
Hong, J., Valenzuela, A., Fiorentino, D., & Chung, L. (2014). Muscle Disease in Systemic Sclerosis Is Associated with an Increased Risk for Cardiac Involvement. ARTHRITIS & RHEUMATOLOGY, 66, S314–S315. -
Effect of the ETA Selective Endothelin Receptor Antagonist Ambrisentan on Digital Ulcers in Patients with Systemic Sclerosis: Results of a Prospective Pilot Study.
Chung, L., Arefiev, K., Yaqub, A., Strahs, D., Lingala, B., & Fiorentino, D. (2011). Effect of the ETA Selective Endothelin Receptor Antagonist Ambrisentan on Digital Ulcers in Patients with Systemic Sclerosis: Results of a Prospective Pilot Study. ARTHRITIS AND RHEUMATISM, 63(10), S259–S260. -
INVESTIGATING THE PLASMA CELL SIGNATURE IN AUTOIMMUNE DISEASE
Streicher, K., Morehouse, C., Groves, C., Rajan, B., Pilataxi, F., Lehmann, K., … Ranade, K. (2013). INVESTIGATING THE PLASMA CELL SIGNATURE IN AUTOIMMUNE DISEASE. ANNALS OF THE RHEUMATIC DISEASES, 72, 166. -
Identification Of Clinical Features and Risk Factors Associated With Calcinosis In Adult Patients With Dermatomyositis
Valenzuela, A., Chung, L., Casciola-Rosen, L., Rosen, A., & Fiorentino, D. (2013). Identification Of Clinical Features and Risk Factors Associated With Calcinosis In Adult Patients With Dermatomyositis. ARTHRITIS AND RHEUMATISM, 65, S889. -
Antibodies to NXP-2 and Transcriptional Intermediary Factor-Gamma Identify Patients with Cancer-Associated Dermatomyositis.
Fiorentino, D., Christopher-Stine, L., Chung, L., Lingala, B., Mammen, A. L., Rosen, A., & Casciola-Rosen, L. (2012). Antibodies to NXP-2 and Transcriptional Intermediary Factor-Gamma Identify Patients with Cancer-Associated Dermatomyositis. ARTHRITIS AND RHEUMATISM, 64(10), S828. -
Comparison of responders and non-responders to MQX-503, a novel investigational topical nitroglycerin formulation, in treatment of scieroderma-related and non-scleroderma-related Raynaud'S phenomenon
Herrick, A., Denton, C., Fiorentino, D., Sule, S., Rothfield, N., Belch, J., … Gregory, J. (2008). Comparison of responders and non-responders to MQX-503, a novel investigational topical nitroglycerin formulation, in treatment of scieroderma-related and non-scleroderma-related Raynaud'S phenomenon. ARTHRITIS AND RHEUMATISM, 58(9), S822. -
Immunosignature Technology Differentiates Patients with Systemic Sclerosis and Internal Organ Involvement
Chung, L., Fiorentino, D., Gerwien, R., Jia, K., Legutki, J. B., Vergara, A. V., … Sykes, K. (2016). Immunosignature Technology Differentiates Patients with Systemic Sclerosis and Internal Organ Involvement. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Serious infection events in the psoriasis longitudinal assessment and registry study: current status of observations
Leonardi, C., Fiorentino, D., Kalb, R., & Chevrier, M. (2013). Serious infection events in the psoriasis longitudinal assessment and registry study: current status of observations. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 27, 7–8. -
An open-label trial of treprostenil for the treatment and prevention of digital ischemic lesions in patients with systemic sclerosis
Chung, L., & Fiorentino, D. (2005). An open-label trial of treprostenil for the treatment and prevention of digital ischemic lesions in patients with systemic sclerosis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 52(3), P65. -
Current status of observations of malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Langholff, W. (2016). Current status of observations of malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 30, 13–14. -
Comparative effectiveness of biological therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Study
Strober, B., Bissonnette, R., Fiorentino, D., Kimball, A. B., Lebwohl, M., Naldi, L., … Fakharzadeh, S. (2016). Comparative effectiveness of biological therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Study. BRITISH JOURNAL OF DERMATOLOGY, 175, 72–73. -
Malignancy events in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) study: Current status of observations
Fiorentino, D., Langley, R., Fakharzadeh, S., & Ho, V. (2014). Malignancy events in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) study: Current status of observations. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(5), AB175. -
Drug repurposing for dermatomyositis using public expression datasets
Cho, H. G., Fiorentino, D. F., Sirota, M., & Sarin, K. (2015). Drug repurposing for dermatomyositis using public expression datasets. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 135, S70. -
Serious infection events in the psoriasis longitudinal assessment and registry (PSOLAR) study: Current status of observations
Leonardi, C., Fiorentino, D., Chevrier, M., & Kalb, R. (2013). Serious infection events in the psoriasis longitudinal assessment and registry (PSOLAR) study: Current status of observations. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 68(4), AB213. -
Serious infection events in the Psoriasis Longitudinal Assessment and Registry Study (PSOLAR): Current status of observations
Kalb, R. E., Fiorentino, D., Lebwohl, M., Leonardi, C., Toole, J., Poulin, Y., … Fakharzadeh, S. (2015). Serious infection events in the Psoriasis Longitudinal Assessment and Registry Study (PSOLAR): Current status of observations. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(5), AB252. -
Malignancy events in the psoriasis longitudinal assessment and registry study: current status of observations
Langley, R., Strober, B., Lebwohl, M., Ho, V., Fiorentino, D., Fakharzadeh, S., … Chevrier, M. (2013). Malignancy events in the psoriasis longitudinal assessment and registry study: current status of observations. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 27, 23–24. -
Cutaneous Ulceration in Dermatomyositis: Association with MDA-5 and Interstitial Lung Disease.
Narang, N., Casciola-Rosen, L., Rosen, A., Fiorentino, D., & Chung, L. (2012). Cutaneous Ulceration in Dermatomyositis: Association with MDA-5 and Interstitial Lung Disease. ARTHRITIS AND RHEUMATISM, 64(10), S326. -
Dermatomyositis Autoantibodies Clinical Markers of Patients Past, Present, and Future
Fiorentino, D., & Werth, V. P. (2011). Dermatomyositis Autoantibodies Clinical Markers of Patients Past, Present, and Future. ARCHIVES OF DERMATOLOGY, 147(4), 492–94. -
PSOLAR: Update of a multicenter registry of patients with psoriasis who are candidates for systemic therapy including biologics
Strober, B. E., Kimball, A., Fiorentino, D., & Chevrier, M. (2011). PSOLAR: Update of a multicenter registry of patients with psoriasis who are candidates for systemic therapy including biologics. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 64(2), AB150. -
A pilot trial of treprostinil (Remodulin (R)) for the treatment and prevention of digital ischemic lesions in patients with systemic sclerosis.
Chung, L., & Fiorentino, D. (2004). A pilot trial of treprostinil (Remodulin (R)) for the treatment and prevention of digital ischemic lesions in patients with systemic sclerosis. ARTHRITIS AND RHEUMATISM, 50(12), 4086. -
A Consensus Hybrid Definition Using a Conjoint Analysis Is the Proposed As Response Criteria for Minimal and Moderate Improvement for Adult Polymyositis and Dermatomyositis Clincal Trials.
Aggarwal, R., Rider, L. G., Ruperto, N., Bayat, N., Erman, B., Feldman, B. M., … Vencovsky, J. (2014). A Consensus Hybrid Definition Using a Conjoint Analysis Is the Proposed As Response Criteria for Minimal and Moderate Improvement for Adult Polymyositis and Dermatomyositis Clincal Trials. ARTHRITIS & RHEUMATOLOGY, 66, S404–S405. -
Validation Of The Cutaneous Dermatomyositis Disease Area and Severity Index: Characterizing Severity and Assessing Responsiveness To Clinical Change
Anyanwu, C. O., Fiorentino, D., Chung, L., Wang, Y., Propert, K. J., & Werth, V. P. (2013). Validation Of The Cutaneous Dermatomyositis Disease Area and Severity Index: Characterizing Severity and Assessing Responsiveness To Clinical Change. ARTHRITIS AND RHEUMATISM, 65, S824. -
Evaluating quality of life in dermatomyositis
Goreshi, R., Chock, M., Fiorentino, D., Feng, R., Foering, K., Okawa, J., … Werth, V. P. (2010). Evaluating quality of life in dermatomyositis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130, S54. -
Evidence supports blind screening for internal malignancy in dermatomyositis Data from 2 large US dermatology cohorts
Leatham, H., Schadt, C., Chisolm, S., Fretwell, D., Chung, L., Callen, J. P., & Fiorentino, D. (2018). Evidence supports blind screening for internal malignancy in dermatomyositis Data from 2 large US dermatology cohorts. MEDICINE, 97(2), e9639. -
Ustekinumab improved health-related quality of life in patients with psoriasis in a real world setting: Results from PSOLAR
Strober, B., Bissonnette, R., Fiorentino, D., Kimball, A. B., Lebwohl, M., Naldi, L., … Goyal, K. (2016). Ustekinumab improved health-related quality of life in patients with psoriasis in a real world setting: Results from PSOLAR. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(5), AB281. -
Pregnancy Outcomes In Adult Patients With Dermatomyositis and Polymyositis
Chung, L., Fiorentino, D., Li, S., & Chakravarty, E. (2013). Pregnancy Outcomes In Adult Patients With Dermatomyositis and Polymyositis. ARTHRITIS AND RHEUMATISM, 65, S886–S887. -
International Classification of Diseases-Clinical Modification-9 Codes for the Diagnosis of Dermatomyositis and Polymyositis in Discharge Summaries: Evidence of Acceptable Validity
Narang, N., Fiorentino, D., Krishnan, E., & Chung, L. (2011). International Classification of Diseases-Clinical Modification-9 Codes for the Diagnosis of Dermatomyositis and Polymyositis in Discharge Summaries: Evidence of Acceptable Validity. ARTHRITIS AND RHEUMATISM, 63(10), S90. -
The yin and yang of TNF-alpha inhibition
Fiorentino, D. F. (2007). The yin and yang of TNF-alpha inhibition. ARCHIVES OF DERMATOLOGY, 143(2), 233–36. -
Multi-Organ RNA-Sequencing of Systemic Sclerosis (SSc) Patients Shows Reproducible Gene Expression Profiles Across Organ Systems
Mehta, B. K., Johnson, M. E., Archambault, K. A., Wood, T. A., Valenzuela, A., Crawford, A., … Whitfield, M. (2016). Multi-Organ RNA-Sequencing of Systemic Sclerosis (SSc) Patients Shows Reproducible Gene Expression Profiles Across Organ Systems. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Calcinosis Is Associated with Digital Ulcers and Osteoporosis in Patients with Systemic Sclerosis
Valenzuela, A., Baron, M., Herrick, A. L., Proudman, S., Stevens, W., Sofia Rodriguez-Reyna, T., … Chung, L. (2015). Calcinosis Is Associated with Digital Ulcers and Osteoporosis in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 67. -
Validation Of a Novel Radiographic Scoring System For Calcinosis Affecting The Hands Of Patients With Systemic Sclerosis.
Chung, L., Vergara, A. M. V., Fiorentino, D., Stevens, K., Li, S., Harris, J., … Baron, M. (2013). Validation Of a Novel Radiographic Scoring System For Calcinosis Affecting The Hands Of Patients With Systemic Sclerosis. ARTHRITIS AND RHEUMATISM, 65, S289–S290. -
Comparative effectiveness of biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Study
Strober, B., Bissonnette, R., Fiorentino, D., Kimball, A. B., Lebwohl, M., Naldi, L., … Fakharzadeh, S. (2016). Comparative effectiveness of biologic therapy in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(5), AB240. -
Current status of observations of malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Langholff, W. (2016). Current status of observations of malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(5), AB243. -
Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument
Yassaee, M., Fiorentino, D., Taylor, L., Coley, C., Troxel, A. B., & Werth, V. (2009). Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 129, S43. -
DESIGN OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL OF THE TOLL-LIKE RECEPTOR ANTAGONIST IMO-8400 IN PATIENTS WITH DERMATOMYOSITIS
Gordon, P., Cooper, R., Chinoy, H., Isenberg, D., Lundberg, I. E., Werth, V., … Fiorentino, D. (2016). DESIGN OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL OF THE TOLL-LIKE RECEPTOR ANTAGONIST IMO-8400 IN PATIENTS WITH DERMATOMYOSITIS. ANNALS OF THE RHEUMATIC DISEASES, 75, 1119. -
GENOMIC SIGNATURES CHARACTERIZE LEUKOCYTE INFILTRATION IN MYOSITIS MUSCLES
Zhu, W., Streicher, K., Shen, N., Higgs, B. W., Morehouse, C., Greenlees, L., … Yao, Y. (2013). GENOMIC SIGNATURES CHARACTERIZE LEUKOCYTE INFILTRATION IN MYOSITIS MUSCLES. ANNALS OF THE RHEUMATIC DISEASES, 71, 472. -
Rituximab in the treatment of patients with dermatomyositis: 12 week interim analysis of a pilot trial.
Chung, L., Genovese, M. C., & Fiorentino, D. (2005). Rituximab in the treatment of patients with dermatomyositis: 12 week interim analysis of a pilot trial. ARTHRITIS AND RHEUMATISM, 52(12), 4088. -
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects
Rider, L. G., Ruperto, N., Pistorio, A., Erman, B., Bayat, N., Lachenbruch, P. A., … Aggarwal, R. (2017). 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. RHEUMATOLOGY, 56(11), 1884–93. -
Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems
Mehta, B. K., Franks, J., Cai, G., Toledo, D., Wood, T. A., Archambault, K. A., … Whitfield, M. L. (2017). Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Sifalimumab, an Anti-IFN-Alpha Monoclonal Antibody Shows Target Suppression of a Type I IFN Signature in Blood and Muscle of Dermatomyositis and Polymyositis Patients.
Higgs, B. W., Zhu, W., Morehouse, C., White, W., Brohawn, P., Le, C., … Yao, Y. (2012). Sifalimumab, an Anti-IFN-Alpha Monoclonal Antibody Shows Target Suppression of a Type I IFN Signature in Blood and Muscle of Dermatomyositis and Polymyositis Patients. ARTHRITIS AND RHEUMATISM, 64(10), S325. -
Current status of observations of malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) study
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Langholff, W. (2016). Current status of observations of malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) study. EXPERIMENTAL DERMATOLOGY, 25, 48–49. -
Serious Infection Events in the Psoriasis Longitudinal Assessment and Registry Study: Cumulative Experience.
Kalb, R., Fiorentino, D., Lebwohl, M., Leonardi, C., Toole, J., Goyal, K., … Fakharzadeh, S. (2014). Serious Infection Events in the Psoriasis Longitudinal Assessment and Registry Study: Cumulative Experience. ARTHRITIS & RHEUMATOLOGY, 66, S814. -
MOLECULAR CHARACTERIZATION OF COLLAGEN IN MUSCLE OF POLYMYOSITIS AND DERMATOMYOSITIS
Liu, Z., Morehouse, C., Higgs, B. W., Czapiga, M., Rebelatto, M., Brohawn, P., … Yao, Y. (2013). MOLECULAR CHARACTERIZATION OF COLLAGEN IN MUSCLE OF POLYMYOSITIS AND DERMATOMYOSITIS. ANNALS OF THE RHEUMATIC DISEASES, 71, 477–78. -
Evaluation of malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Langholff, W. (2015). Evaluation of malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). BRITISH JOURNAL OF DERMATOLOGY, 173, 59. -
Similar topology of injury to keratinocytes and myofibres in dermatomyositis skin and muscle
Greenberg, S. A., & Fiorentino, D. (2009). Similar topology of injury to keratinocytes and myofibres in dermatomyositis skin and muscle. BRITISH JOURNAL OF DERMATOLOGY, 160(2), 464–65. -
Re-examining mechanic's hands as a characteristic skin finding in dermatomyositis
Concha, J. S. S., Merola, J. F., Fiorentino, D., & Werth, V. P. (2018). Re-examining mechanic's hands as a characteristic skin finding in dermatomyositis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 78(4), 769-+. -
Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis
Wolstencroft, P. W., Chung, L., Li, S., Casciola-Rosen, L., & Fiorentino, D. F. (2018). Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis. JAMA DERMATOLOGY, 154(1), 44–51. -
A Phase I Single-Dose Crossover Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy Of AMG 811 (anti-IFN-gamma) In Subjects With Discoid Lupus Erythematosus
Werth, V. P., Fiorentino, D., Cohen, S. B., Fivenson, D., Hansen, C., Zoog, S., … Martin, D. A. (2013). A Phase I Single-Dose Crossover Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy Of AMG 811 (anti-IFN-gamma) In Subjects With Discoid Lupus Erythematosus. ARTHRITIS AND RHEUMATISM, 65, S682–S683. -
MALIGNANCIES IN THE PSORIASIS LONGITUDINAL ASSESSMENT AND REGISTRY (PSOLAR) STUDY: CURRENT STATUS OF OBSERVATIONS
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Langholff, W. (2015). MALIGNANCIES IN THE PSORIASIS LONGITUDINAL ASSESSMENT AND REGISTRY (PSOLAR) STUDY: CURRENT STATUS OF OBSERVATIONS. ANNALS OF THE RHEUMATIC DISEASES, 74, 862. -
Comprehensive Characterization of Calcinosis in a Multicenter International Cohort of Patients with Systemic Sclerosis
Valenzuela, A., Gordon, J. K., Sofia Rodriguez-Reyna, T., Proudman, S., Baron, M., Hinchcliff, M., … Chung, L. (2016). Comprehensive Characterization of Calcinosis in a Multicenter International Cohort of Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 68. -
Nomenclature of Cutaneous Vasculitis Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Sunderkoetter, C. H., Zelger, B., Chen, K.-R., Requena, L., Piette, W., Carlson, J. A., … Jennette, J. C. (2018). Nomenclature of Cutaneous Vasculitis Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. ARTHRITIS & RHEUMATOLOGY, 70(2), 171–84. -
Activity of Type I and Type II Interferons in Dermatomyositis Skin Is Correlated with Characteristic Pathologic Features
Leatham, H. W., Rieger, K., Chung, L., Li, S., Higgs, B. W., Yao, Y., … Fiorentino, D. (2015). Activity of Type I and Type II Interferons in Dermatomyositis Skin Is Correlated with Characteristic Pathologic Features. ARTHRITIS & RHEUMATOLOGY, 67. -
MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon
Belch, J., Fiorentino, D., Denton, C., Herrick, A., Sule, S., Steen, V., … Gregory, J. K. (2008). MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon. ARTHRITIS AND RHEUMATISM, 58(9), S622. -
Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry
Fiorentino, D., Ho, V., Lebwohl, M. G., Leite, L., Hopkins, L., Galindo, C., … Langley, R. G. (2017). Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 77(5), 845-+. -
Malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study: Current status of observations
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Langholff, W. (2015). Malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study: Current status of observations. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(5), AB240. -
Serious infection events in the Psoriasis Longitudinal Assessment and Registry Study: current status of observations
Kalb, R., Fiorentino, D., Lebwohl, M., Leonardi, C., Toole, J., Goyal, K., … Fakharzadeh, S. (2014). Serious infection events in the Psoriasis Longitudinal Assessment and Registry Study: current status of observations. BRITISH JOURNAL OF DERMATOLOGY, 171(6), E165–E166. -
Cutaneous Lupus Erythematosus
Fiorentino, D. F., & Sontheimer, R. D. (2009). Cutaneous Lupus Erythematosus. CLINICAL AND BASIC IMMUNODERMATOLOGY, 703–19. -
Antibodies to Human Interferon-Inducible Protein-16 Are Present in Primary Sjogren's Syndrome and Systemic Lupus, but Are Rare in Dermatomyositis.
Baer, A. N., Petri, M., Fiorentino, D., Wang, T., Sohn, J., Rosen, A., & Casciola-Rosen, L. (2014). Antibodies to Human Interferon-Inducible Protein-16 Are Present in Primary Sjogren's Syndrome and Systemic Lupus, but Are Rare in Dermatomyositis. ARTHRITIS & RHEUMATOLOGY, 66, S1110. -
Use of imatinib to treat systemic sclerosis: A prospective case series
Arefiev, K., Fiorentino, D., Chung, L., & Robinson, W. (2009). Use of imatinib to treat systemic sclerosis: A prospective case series. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 60(3), AB3. -
Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon
Rothfield, N., Shapiro, L., Fiorentino, D., Chung, L., Denton, C., Herrick, A., … Wigey, F. M. (2008). Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon. ARTHRITIS AND RHEUMATISM, 58(9), S821. -
An open-label trial of rituximab in the treatment of patients with dermatomyositis
Chung, L., & Fiorentino, D. (2006). An open-label trial of rituximab in the treatment of patients with dermatomyositis. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 54(3), AB77. -
Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis
Dave, A. J., Lingala, B., Fiorentino, D., Krishnan, E., & Chung, L. (2012). Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM, 64(10), S302–S303. -
Clinical characteristics and treatment response of patients with dermatomyositis seen at a tertiary dermatology department: The Stanford experience
Sanderson, E. A., Chung, L. S., & Fiorentino, D. F. (2008). Clinical characteristics and treatment response of patients with dermatomyositis seen at a tertiary dermatology department: The Stanford experience. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 128(6), 1606. -
Dual mTOR Inhibition Is Required to Prevent TGF-beta-Mediated Fibrosis: Implications for Scleroderma
Mitra, A., Luna, J. I., Marusina, A. I., Merleev, A., Kundu-Raychaudhuri, S., Fiorentino, D., … Maverakis, E. (2015). Dual mTOR Inhibition Is Required to Prevent TGF-beta-Mediated Fibrosis: Implications for Scleroderma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 135(11), 2873–76. -
Transcriptome Sequencing Reveals Genetic Polymorphisms Associated with Ssc Gene Expression Subtypes
Cai, G., Mehta, B. K., Huang, M., Franks, J., Wood, T. A., Kolstad, K. D., … Whitfield, M. L. (2017). Transcriptome Sequencing Reveals Genetic Polymorphisms Associated with Ssc Gene Expression Subtypes. ARTHRITIS & RHEUMATOLOGY, 69. -
Characterization of patients with clinical overlap of morphea and systemic sclerosis: A case series
Chen, J. K., Chung, L., & Fiorentino, D. F. (2016). Characterization of patients with clinical overlap of morphea and systemic sclerosis: A case series. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 74(6), 1272–74. -
Malignancies in the Psoriasis Longitudinal Assessment and Registry Study: Cumulative Experience
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Langholff, W. (2014). Malignancies in the Psoriasis Longitudinal Assessment and Registry Study: Cumulative Experience. ARTHRITIS & RHEUMATOLOGY, 66, S690. -
Factors Associated with Clinical Remission of Skin Disease in Dermatomyositis
Wolstencroft, P., Chung, L., Li, S., Casciola-Rosen, L., & Fiorentino, D. (2017). Factors Associated with Clinical Remission of Skin Disease in Dermatomyositis. ARTHRITIS & RHEUMATOLOGY, 69. -
Malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study: current status of observations
Fiorentino, D., Lebwohl, M., Ho, V., Langley, R., Goyal, K., Fakharzadeh, S., … Lanholff, W. (2014). Malignancies in the psoriasis longitudinal assessment and registry (PSOLAR) study: current status of observations. EXPERIMENTAL DERMATOLOGY, 23, 4. -
SERIOUS INFECTION EVENTS IN THE PSORIASIS LONGITUDINAL ASSESSMENT AND REGISTRY STUDY: CURRENT STATUS OF OBSERVATIONS
Kalb, R., Fiorentino, D., Lebwohl, M., Leonardi, C., Toole, J., Poulin, Y., … Fakharzadeh, S. (2015). SERIOUS INFECTION EVENTS IN THE PSORIASIS LONGITUDINAL ASSESSMENT AND REGISTRY STUDY: CURRENT STATUS OF OBSERVATIONS. ANNALS OF THE RHEUMATIC DISEASES, 74, 862–63. -
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum A Delphi Consensus of International Experts
Maverakis, E., Ma, C., Shinkai, K., Fiorentino, D., Callen, J. P., Wollina, U., … Cheng, M. Y. (2018). Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum A Delphi Consensus of International Experts. JAMA DERMATOLOGY, 154(4), 461–66. -
Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis
Tartar, D. M., Chung, L., & Fiorentino, D. F. (2018). Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis. CLINICS IN DERMATOLOGY, 36(4), 508–24. -
Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.
Wolstencroft, P. W., Casciola-Rosen, L., & Fiorentino, D. F. (2018). Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis. JAMA Dermatology. -
Developing a Classification Criteria for Cutaneous Dermatomyositis Utilizing the Delphi Technique
Concha, J., Werth, V. P., Merola, J. F., Fiorentino, D., Dutz, J., Fujimoto, M., … Vbc-Platzer, B. (2018). Developing a Classification Criteria for Cutaneous Dermatomyositis Utilizing the Delphi Technique. ARTHRITIS & RHEUMATOLOGY, 70. -
Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems
Mehta, B. K., Franks, J., Wang, Y., Cai, G., Toledo, D. M., Wood, T. A., … Whitfield, M. L. (2018). Multi-Organ RNA-Sequencing of Patients with Systemic Sclerosis (SSc) Finds That Intrinsic Subsets Are Conserved across Organ Systems. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Identification of Risk Factors for Gastric Antral Vascular Ectasia (GAVE) Among Systemic Sclerosis Patients
Serling-Boyd, N., Li, S., Fiorentino, D., Becker, L., Fernandez-Becker, N., Clarke, J., & Chung, L. (2018). Identification of Risk Factors for Gastric Antral Vascular Ectasia (GAVE) Among Systemic Sclerosis Patients. ARTHRITIS & RHEUMATOLOGY, 70. -
New validated diagnostic criteria for pyoderma gangrenosum.
Maverakis, E., Le, S. T., Callen, J., Wollina, U., Marzano, A. V., Wallach, D., … Fiorentino, D. (2018). New validated diagnostic criteria for pyoderma gangrenosum. Journal of the American Academy of Dermatology. -
Supplementing Dermatology Physician Resident Education in Vasculitis and Autoimmune Connective Tissue Disease: A Prospective Study of an Online Curriculum.
Haemel, A., Kahl, L., Callen, J., Werth, V. P., Fiorentino, D., & Fett, N. (2019). Supplementing Dermatology Physician Resident Education in Vasculitis and Autoimmune Connective Tissue Disease: A Prospective Study of an Online Curriculum. JAMA Dermatology. -
Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations
Concha, J. S. S., Patsatsi, A., Marshak-Rothstein, A., Liu, M.-lin, Sinha, A. A., Lee, L. A., … Werth, V. P. (2019). Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(2), 270–76. -
Clinical factors associated with cutaneous histopathologic findings in dermatomyositis.
Wolstencroft, P. W., Rieger, K. E., Leatham, H. W., & Fiorentino, D. F. (2019). Clinical factors associated with cutaneous histopathologic findings in dermatomyositis. Journal of Cutaneous Pathology. -
Clinical factors associated with cutaneous histopathologic findings in dermatomyositis
Wolstencroft, P. W., Rieger, K. E., Leatham, H. W., & Fiorentino, D. F. (2019). Clinical factors associated with cutaneous histopathologic findings in dermatomyositis. JOURNAL OF CUTANEOUS PATHOLOGY, 46(6), 401–10. -
DESIGN OF PHASE 3 STUDY OF LENABASUM FOR THE TREATMENT OF DERMATOMYOSITIS
Werth, V., Oddis, C. V., Lundberg, I. E., Fiorentino, D., Cornwall, C., Dgetluck, N., … White, B. (2019). DESIGN OF PHASE 3 STUDY OF LENABASUM FOR THE TREATMENT OF DERMATOMYOSITIS. ANNALS OF THE RHEUMATIC DISEASES, 78, 1228. -
Distinct dermatomyositis populations are detected with different autoantibody assay platforms.
Fiorentino, D. F., Gutierrez-Alamillo, L., Hines, D., Yang, Q., & Casciola-Rosen, L. (2019). Distinct dermatomyositis populations are detected with different autoantibody assay platforms. Clinical and Experimental Rheumatology. -
Change in Calcinosis over 1 Year Using the SCTC Radiologic Scoring System for Calcinosis of the Hands in Patients with Systemic Sclerosis
Valenzuela, A., Chung, M., Rodriguez-Reyna, T. S., Proudman, S., Baron, M., Castelino, F., … Chung, L. (2019). Change in Calcinosis over 1 Year Using the SCTC Radiologic Scoring System for Calcinosis of the Hands in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 71. -
Prevalence and Clinical Associations of Degos Lesions in Systemic Sclerosis
Song, P., Chung, M., Li, S., Fiorentino, D., & Chung, L. (2019). Prevalence and Clinical Associations of Degos Lesions in Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 71. -
Skin Disease Activity and Autoantibody Phenotype Are Major Determinants of Blood Interferon Signatures in Dermatomyositis
Tabata, M., Sarin, K., Page, K., Huard, C., Zhao, S., Bennett, D., … Fiorentino, D. (2019). Skin Disease Activity and Autoantibody Phenotype Are Major Determinants of Blood Interferon Signatures in Dermatomyositis. ARTHRITIS & RHEUMATOLOGY, 71. -
A Double-Blind, Placebo-Controlled, Phase 2 Trial of a Novel Toll-Like Receptor 7/8/9 Antagonist (IMO-8400) in Dermatomyositis
Kim, Y. J., Schiopu, E., Danko, K., Mozaffar, T., Chunduru, S., Lees, K., … Sarin, K. (2019). A Double-Blind, Placebo-Controlled, Phase 2 Trial of a Novel Toll-Like Receptor 7/8/9 Antagonist (IMO-8400) in Dermatomyositis. ARTHRITIS & RHEUMATOLOGY, 71. -
Increased Mortality in Asians With Systemic Sclerosis in Northern California.
Chung, M. P., Dontsi, M., Postlethwaite, D., Kesh, S., Simard, J. F., Fiorentino, D., … Chung, L. (2020). Increased Mortality in Asians With Systemic Sclerosis in Northern California. ACR Open Rheumatology. -
Distinct dermatomyositis populations are detected with different autoantibody assay platforms
Fiorentino, D. F., Gutierrez-Alamillo, L., Hines, D., Yang, Q., & Casciola-Rosen, L. (2019). Distinct dermatomyositis populations are detected with different autoantibody assay platforms. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 37(6), 1048–51. -
A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO-8400, in dermatomyositis.
Kim, Y. J., Schiopu, E., Dankó, K., Mozaffar, T., Chunduru, S., Lees, K., … Sarin, K. Y. (2020). A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO-8400, in dermatomyositis. Journal of the American Academy of Dermatology. -
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis.
Valenzuela, A., Baron, M., Rodriguez-Reyna, T. S., Proudman, S., Khanna, D., Young, A., … Chung, L. (2020). Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism, 50(5), 891–96. -
Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies.
Serling-Boyd, N., Chung, M. P.-S., Li, S., Becker, L., Fernandez-Becker, N., Clarke, J., … Chung, L. (2020). Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies. Seminars in Arthritis and Rheumatism, 50(5), 938–42. -
A Mortality Risk Score Model for Clinically Amyopathic Dermatomyositis-Associated Interstitial Lung Disease: Will It Have the Necessary "FLAIR" to Improve Clinical Outcomes?
Baker, M. C., Chung, L., & Fiorentino, D. F. (2020). A Mortality Risk Score Model for Clinically Amyopathic Dermatomyositis-Associated Interstitial Lung Disease: Will It Have the Necessary "FLAIR" to Improve Clinical Outcomes? Chest, 158(4), 1307–9. -
Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.
Liu, Q., Zaba, L., Satpathy, A. T., Longmire, M., Zhang, W., Li, K., … Chang, H. Y. (2020). Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis. Nature Communications, 11(1), 5843. -
Author Correction: Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis.
Liu, Q., Zaba, L. C., Satpathy, A. T., Longmire, M., Zhang, W., Li, K., … Chang, H. Y. (2020). Author Correction: Chromatin accessibility landscapes of skin cells in systemic sclerosis nominate dendritic cells in disease pathogenesis. Nature Communications, 11(1), 6416. -
Preliminary Baseline Subject Demographics and Disease Characteristics in a Phase 3 Clinical Trial of the Safety and Efficacy of Lenabasum in Dermatomyositis (DETERMINE)
Werth, V., Oddis, C., Fiorentino, D., Dgetluck, N., Quinn Dinh, Tillinger, M., … Lundberg, I. (2020). Preliminary Baseline Subject Demographics and Disease Characteristics in a Phase 3 Clinical Trial of the Safety and Efficacy of Lenabasum in Dermatomyositis (DETERMINE). ARTHRITIS & RHEUMATOLOGY, 72. -
Dermatomyositis autoantibodies: how can we maximize utility?
Hodgkinson, L. M., Wu, T. T., & Fiorentino, D. F. (2021). Dermatomyositis autoantibodies: how can we maximize utility? Annals of Translational Medicine, 433. -
A Systematic Review and Meta-Analysis to Inform Cancer Screening Guidelines in Idiopathic Inflammatory Myopathies.
Oldroyd, A. G., Allard, A. B., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., … Aggarwal, R. (2021). A Systematic Review and Meta-Analysis to Inform Cancer Screening Guidelines in Idiopathic Inflammatory Myopathies. Rheumatology (Oxford, England). -
Why rheumatologic skin disease?
Sontheimer, R. D., Connolly, M. K., Fiorentino, D. F., & Werth, V. P. (2021). Why rheumatologic skin disease? ANNALS OF TRANSLATIONAL MEDICINE, 9(5), 428. -
Distinct purpuric lesions in patients with dermatomyositis.
Cho, S. K., Messenger, E., & Fiorentino, D. F. (2021). Distinct purpuric lesions in patients with dermatomyositis. JAAD Case Reports, 13, 94–96. -
Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis.
Liu, S., Chung, M. P., Ley, B., French, S., Elicker, B. M., Fiorentino, D. F., … Wolters, P. J. (2021). Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis. Thorax. -
Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.
Oldroyd, A. G., Allard, A. B., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., … Aggarwal, R. (2021). Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford, England). -
A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Systemic Sclerosis.
Chung, M. P., Valenzuela, A., Li, S., Catanese, B., Stevens, K., Fiorentino, D., … Chung, L. (2021). A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Systemic Sclerosis. Rheumatology (Oxford, England). -
Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence.
Fiorentino, D. F., Mecoli, C. A., Rosen, M. C., Chung, L. S., Christopher-Stine, L., Rosen, A., & Casciola-Rosen, L. (1800). Immune responses to CCAR1 and other dermatomyositis autoantigens are associated with attenuated cancer emergence. The Journal of Clinical Investigation, 132(2). -
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis.
Valenzuela, A., Stevens, K., Chung, M. P., Rodriguez-Reyna, T. S., Proudman, S., Baron, M., … Chung, L. (2022). Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism, 53, 151980. -
Defining anti-synthetase syndrome: a systematic literature review.
Zanframundo, G., Faghihi-Kashani, S., Scire, C. A., Bonella, F., Corte, T. J., Doyle, T. J., … Cavagna, L. (2022). Defining anti-synthetase syndrome: a systematic literature review. Clinical and Experimental Rheumatology, 40(2), 309–319. -
Factors Impacting Likelihood of Discontinuing Immunosuppression in Adult Dermatomyositis: A Single-Center Study
Cho, S. K., Chung, L., & Fiorentino, D. (2021). Factors Impacting Likelihood of Discontinuing Immunosuppression in Adult Dermatomyositis: A Single-Center Study. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Gastrointestinal Perforation in a patient with Anti-nuclear Matrix Protein 2 Antibody Positive Dermatomyositis.
Valenzuela, A., Rieger, K. E., Blish, C. A., Chung, L., & Fiorentino, D. (2022). Gastrointestinal Perforation in a patient with Anti-nuclear Matrix Protein 2 Antibody Positive Dermatomyositis. Arthritis Care & Research. -
Defining anti-synthetase syndrome: a systematic literature review
Zanframundo, G., Faghihi-Kashani, S., Scire, C. A., Bonella, F., Corte, T. J., Doyle, T. J., … Cavagna, L. (2022). Defining anti-synthetase syndrome: a systematic literature review. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 40(2), 309–319. -
Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis.
El-Banna, G., & Fiorentino, D. (2022). Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis. Current Rheumatology Reports. -
Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis.
Fiorentino, D. F., & Casciola-Rosen, L. (2022). Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis. Clinical Reviews in Allergy & Immunology. -
Cessation of immunomodulatory medication use in dermatomyositis: a single center cohort study.
Cho, S. K., Casciola-Rosen, L., Kapoor, P., Chung, L., & Fiorentino, D. (2022). Cessation of immunomodulatory medication use in dermatomyositis: a single center cohort study. Arthritis Care & Research. -
Trial of Intravenous Immune Globulin in Dermatomyositis.
Werth, V. P., Fiorentino, D. F., & Vleugels, R. A. (2023). Trial of Intravenous Immune Globulin in Dermatomyositis. The New England Journal of Medicine, 388(1), 94. -
Extreme Phenotype Approach Identifies Rare Variants in Systemic Sclerosis and Dermatomyositis Patients with Severe Calcinosis
Davuluri, S., Kaundal, U., Lood, C., Kapoor, P., Kawano, Y., Dell'Orso, S., … Chung, L. (2022). Extreme Phenotype Approach Identifies Rare Variants in Systemic Sclerosis and Dermatomyositis Patients with Severe Calcinosis. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Cancer Screening Recommendations for Patients with Idiopathic Inflammatory Myopathy
Oldroyd, A., Callen, J., Chinoy, H., Chung, L., Fiorentino, D., Gordon, P., … Aggarwal, R. (2022). Cancer Screening Recommendations for Patients with Idiopathic Inflammatory Myopathy. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Performance of the 2016 ACR/EULAR Myositis Response Criteria in Adult Dermatomyositis and Polymyositis Therapeutic Trials and Consensus Profiles
Saygin, D., Kim, H., Douglas, C., Erman, B., Wilkerson, J., Mcgrath, J., … Rider, L. G. (2022). Performance of the 2016 ACR/EULAR Myositis Response Criteria in Adult Dermatomyositis and Polymyositis Therapeutic Trials and Consensus Profiles. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Cutaneous Manifestations, Clinical Trials, Safety Efficacy and Safety of Lenabasum in the Phase 3 DeterMine Trial in Dermatomyositis
Werth, V., White, B., Concha, J., Dan, J., Dgetluck, N., Hally, K., … Oddis, C. (2022). Cutaneous Manifestations, Clinical Trials, Safety Efficacy and Safety of Lenabasum in the Phase 3 DeterMine Trial in Dermatomyositis. ARTHRITIS & RHEUMATOLOGY. WILEY. -
Current concepts and advances in dermatomyositis: a dermatological perspective.
Lim, D., Fiorentino, D., & Werth, V. (2023). Current concepts and advances in dermatomyositis: a dermatological perspective. Clinical and Experimental Rheumatology. -
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis.
Song, P., Li, S., Lewis, M. A., Fiorentino, D. F., & Chung, L. (2023). Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis. JAMA Dermatology. -
Anti-CCAR1 autoantibodies are specific for anti-TIF1gamma-positive dermatomyositis and decrease cancer risk relative to the general population.
Fiorentino, D., Mecoli, C. A., Igusa, T., Albayda, J., Paik, J. J., Tiniakou, E., … Casciola-Rosen, L. (2023). Anti-CCAR1 autoantibodies are specific for anti-TIF1gamma-positive dermatomyositis and decrease cancer risk relative to the general population. Arthritis & Rheumatology (Hoboken, N.J.). -
Performance of the 2016 ACR-EULAR myositis response criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
Saygin, D., Kim, H., Douglas, C., Erman, B., Wilkerson, J., McGrath, J. A., … Rider, L. G. (2023). Performance of the 2016 ACR-EULAR myositis response criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. Rheumatology (Oxford, England). -
DEVELOPING CLASSIFICATION CRITERIA FOR SKIN-PRE-DOMINANT DERMATOMYOSITIS: REVIEWING THE PROCESS FROM THE DELPHI METHOD TO INTERNAL VALIDATION
Concha, J. S. S., Merola, J. F., Fiorentino, D., Dutz, J. P., Goodfield, M., Nyberg, F., … Werth, V. P. (2023). DEVELOPING CLASSIFICATION CRITERIA FOR SKIN-PRE-DOMINANT DERMATOMYOSITIS: REVIEWING THE PROCESS FROM THE DELPHI METHOD TO INTERNAL VALIDATION. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. CLINICAL & EXPER RHEUMATOLOGY. -
The type 1 interferon signature reflects multiple phenotypic and activity measures in dermatomyositis.
Tabata, M. M., Hodgkinson, L. M., Wu, T. T., Li, S., Huard, C., Zhao, S., … Fiorentino, D. (2023). The type 1 interferon signature reflects multiple phenotypic and activity measures in dermatomyositis. Arthritis & Rheumatology (Hoboken, N.J.). -
Current concepts and advances in dermatomyositis: a dermatological perspective
Lim, D., Fiorentino, D., & Werth, V. (2023). Current concepts and advances in dermatomyositis: a dermatological perspective. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 41(2), 359–369. -
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical StudiesGroup (IMACS)initiative.
Oldroyd, A. G., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., Gordon, P., … Aggarwal, R. (2023). International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical StudiesGroup (IMACS)initiative. Nature Reviews. Rheumatology. -
Xist ribonucleoproteins promote female sex-biased autoimmunity.
Dou, D. R., Zhao, Y., Belk, J. A., Zhao, Y., Casey, K. M., Chen, D. C., … Chang, H. Y. (2024). Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell, 187(3), 733–749.e16. -
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
Saygin, D., Glaubitz, S., Zeng, R., Bottai, M., de Visser, M., Dimachkie, M. M., … Lundberg, I. E. (2024). Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review. Clinical and Experimental Rheumatology. -
Novel therapeutic targets in dermatomyositis.
Bax, C., Aghdasi, C., & Fiorentino, D. (2024). Novel therapeutic targets in dermatomyositis. The Journal of Dermatology. -
International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus.
Hasegawa, M., Chasset, F., Chong, B. F., Fiorentino, D. F., Fujimoto, M., Nyberg, F., … Werth, V. P. (2024). International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus. The Journal of Dermatology. -
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.
Loganathan, A., Zanframundo, G., Yoshida, A., Faghihi-Kashani, S., Bauer Ventura, I., Dourado, E., … Aggarwal, R. (2024). Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank. Clinical and Experimental Rheumatology, 42(2), 277–287. -
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd, A. G., Callen, J. P., Chinoy, H., Chung, L., Fiorentino, D., Gordon, P., … Aggarwal, R. (2024). Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nature Reviews. Rheumatology. -
Xist Ribonucleoproteins Promote Female Sex-biased Autoimmunity
Dou, D., Zhao, Y., Belk, J., Zhao, Y., Casey, K., Chen, D., … Chang, H. (2023). Xist Ribonucleoproteins Promote Female Sex-biased Autoimmunity. ARTHRITIS & RHEUMATOLOGY. WILEY.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Autoimmune Skin Disease Clinic Redwood City, CA
Redwood City, CAAutoimmune Skin Disease Clinic
450 Broadway Street, Pavilion B, 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information » Getting Here »Psoriasis Clinic Redwood City, CA
Redwood City, CAPsoriasis Clinic
450 Broadway Street, Pavilion B, 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information » Getting Here »General Dermatology Clinic in Redwood City Redwood City, CA
Redwood City, CAGeneral Dermatology Clinic in Redwood City
450 Broadway Street, Pavilion B, 4th Floor
Redwood City , CA 94063
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(125 reviews)
View More »
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records